![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Ahmadzadehfar, Hojjat; Matern, Ralf; Baum, Richard P.; Seifert, Robert; Kessel, Katharina; Boegemann, Martin; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Svirydenka, Hanna; Sathekge, Mike; Kabasakal, Levent; Yordanova, Anna; Garcia-Perez, Francisco Osvaldo; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana; Virgolini, Irene und Rahbar, Kambiz
(2021):
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [Lu-177]Lu-PSMA-617: a WARMTH multicentre study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 12: S. 4067-4076
Schindler, Philipp; Masthoff, Max; Harders, Fabian; Schmidt, Hartmut H.; Stegger, Lars; Pascher, Andreas; Rahbar, Kambiz; Wildgruber, Moritz und Köhler, Michael
(2021):
Efficacy of Y-90-Radioembolization in Metastatic Colorectal Cancer Depending on the Primary Tumor Side.
In: Digestive Diseases, Bd. 39, Nr. 4: S. 351-357
Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P.; Seifert, Robert; Kessel, Katharina; Boegemann, Martin; Kulkarni, Harshad R.; Zhang, Jingjing; Gerke, Carolin; Fimmers, Rolf; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Maffey-Steffan, Johanna; Sathekge, Mike; Kabasakal, Levent; Osvaldo Garcia-Perez, Francisco; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana und Virgolini, Irene
(2020):
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [Lu-177]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 1: S. 113-122
Masthoff, Max; Schindler, Philipp; Harders, Fabian; Heindel, Walter; Wilms, Christian; Schmidt, Hartmut H.; Pascher, Andreas; Stegger, Lars; Rahbar, Kambiz; Kohler, Michael und Wildgruber, Moritz
(2020):
Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers.
In: Journal of Cancer Research and Clinical Oncology, Bd. 147, Nr. 5: S. 1537-1545
Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Kratochwil, Clemens; Haberkorn, Uwe; Schaefers, Michael; Essler, Markus; Baum, Richard P.; Kulkarni, Harshad R.; Schmidt, Matthias; Drzezga, Alexander; Bartenstein, Peter; Pfestroff, Andreas; Luster, Markus; Luetzen, Ulf; Marx, Marlies; Prasad, Vikas; Brenner, Winfried; Heinzel, Alexander; Mottaghy, Felix M.; Ruf, Juri; Meyer, Philipp Tobias; Heuschkel, Martin; Eveslage, Maria; Boegemann, Martin; Fendler, Wolfgang Peter und Krause, Bernd Joachim
(2020):
German Multicenter Study Investigating Lu-177-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
In: Journal of Nuclear Medicine, Bd. 61:
257S-262S
Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Kratochwil, Clemens; Haberkorn, Uwe; Schäfers, Michael; Essler, Markus; Baum, Richard P.; Kulkarni, Harshad R.; Schmidt, Matthias; Drzezga, Alexander; Bartenstein, Peter; Pfestroff, Andreas; Luster, Markus; Lützen, Ulf; Marx, Marlies; Prasad, Vikas; Brenner, Winfried; Heinzel, Alexander; Mottaghy, Felix M.; Ruf, Juri; Meyer, Philipp Tobias; Heuschkel, Martin; Eveslage, Maria; Bögemann, Martin; Fendler, Wolfgang Peter und Krause, Bernd Joachim
(2017):
German Multicenter Study Investigating Lu-177-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
In: Journal of Nuclear Medicine, Bd. 58, Nr. 1: S. 85-90
Fendler, Wolfgang P.; Rahbar, Kambiz; Herrmann, Ken; Kratochwil, Clemens und Eiber, Matthias
(2017):
Lu-177-PSMA Radioligand Therapy for Prostate Cancer.
In: Journal of Nuclear Medicine, Bd. 58, Nr. 8: S. 1196-1200
Fendler, Wolfgang P.; Kratochwil, Clemens; Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P.; Schmidt, Matthias; Pfestroff, Andreas; Lützen, Ulf; Prasad, Vikas; Heinzel, Alexander; Heuschkel, Martin; Ruf, Juri; Bartenstein, Peter und Krause, Bernd J.
(2016):
Therapie mit 177Lu-PSMA-617, Dosimetrie und Nachsorge beim metastasierten kastrationsresistenten Prostatakarzinom.
In: Nuklearmedizin, Bd. 55, Nr. 3: S. 123-128